XML 22 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Deficit (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jun. 17, 2019
Feb. 25, 2019
Jan. 02, 2019
Jan. 24, 2018
Jan. 02, 2017
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Stock options outstanding             3,835,366 3,846,299 3,566,299  
Stock options outstanding weighted average exercise price             $ 1.34 $ 1.36 $ 1.33  
Stock options intrinsic value             $ 635,536 $ 2,150,912    
Number of stock options granted             126,567 280,000    
Stock option weighted average exercise price per share             $ 1.15 $ 1.75    
Stock options granted, term             7 years 2 months 12 days 8 years 18 days    
Number of stock options vested             584,895 972,651    
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition             3 years 11 months 23 days      
Debt instrument, face amount             $ 665,000      
Accrued interest             $ 35,000      
Class of warrant or right, outstanding             3,826,658 3,826,658    
Class of warrant or right, outstanding, weighted average exercise price             $ 1.05 $ 1.05    
Class of warrant or right, outstanding, intrinsic value             $ 1,375,990 $ 3,633,335    
Series B Preferred Stock [Member] | Predecessor Warrants [Member]                    
Class of warrant or right, number of securities called by warrants or rights             295,945      
Class of warrant or right, exercise price of warrants or rights             $ 1.25      
Series B Preferred Stock [Member] | Placement Agent Warrants [Member]                    
Class of warrant or right, number of securities called by warrants or rights             127,346      
Class of warrant or right, exercise price of warrants or rights             $ 1.25      
Series B Preferred Stock [Member] | Private Placement [Member]                    
Class of warrant or right, number of securities called by warrants or rights             423,291      
Class of warrant or right, exercise price of warrants or rights                   $ 1.25
Class of warrant or right, expiration period             5 years      
Series B Preferred Stock [Member] | Private Placement [Member] | Protagenic Warrants [Member]                    
Class of warrant or right, number of securities called by warrants or rights             3,403,367      
Class of warrant or right, exercise price of warrants or rights             $ 1.05      
Employees [Member]                    
Compensation expense             $ 562,734      
Unamortized stock option expense             287,905      
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized             144,423      
Non-Employees [Member]                    
Compensation expense             235,027      
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized             $ 143,482      
Four Consultant [Member]                    
Number of stock options granted           80,000        
Stock options granted, term           10 years        
Stock options vesting, term           48 months        
Stock option exercise price           $ 1.75        
Number of stock options vested           50,000        
Number of options expected to vest           30,000        
Stock Option [Member]                    
Number of stock options granted             126,567 280,000    
Stock option weighted average exercise price per share             $ 1.00 $ 1.25    
Compensation expense             $ 797,761 $ 1,130,071    
Stock Options [Member]                    
Number of stock options granted 25,000 101,567                
Stock option weighted average exercise price per share $ 1.75 $ 1.00                
Stock options granted, term 10 years 10 years                
Number of stock options vested   59,900                
Stock options fair value $ 36,374 $ 199,807                
Number of options shares issued for settlement   59,900                
Settlement amount   $ 29,850                
Loss in settlement   $ 99,541                
Stock Options [Member] | Vest bi-Weekly Over Two Months [Member]                    
Number of stock options vested   41,667                
The 2016 Plan [Member]                    
Number of additional shares grants for issuance     564,378   564,378          
Number of shares available for grant     1,693,134   1,693,134   4,304,245      
Share-based payment award, expiration period             10 years      
2016 Equity Compensation Plan [Member] | Consulting Agreement [Member]                    
Number of stock options granted       200,000            
Stock options granted, term       10 years            
Stock options vesting, term       48 months            
Stock option exercise price       $ 1.75